117 related articles for article (PubMed ID: 34299325)
1. Trop2 Expression in Extramammary Paget's Disease and Normal Skin.
Ito T; Tanegashima K; Tanaka Y; Hashimoto H; Murata M; Oda Y; Kaku-Ito Y
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299325
[TBL] [Abstract][Full Text] [Related]
2. NECTIN4-targeted antibody-drug conjugate is a potential therapeutic option for extramammary Paget disease.
Tanaka Y; Ito T; Murata M; Tanegashima K; Kaku-Ito Y; Nakahara T
Exp Dermatol; 2024 Mar; 33(3):e15049. PubMed ID: 38509717
[TBL] [Abstract][Full Text] [Related]
3. Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan.
Zeybek B; Manzano A; Bianchi A; Bonazzoli E; Bellone S; Buza N; Hui P; Lopez S; Perrone E; Manara P; Zammataro L; Altwerger G; Han C; Tymon-Rosario J; Menderes G; Ratner E; Silasi DA; Huang GS; Azodi M; Schwartz PE; Santin A
Sci Rep; 2020 Jan; 10(1):973. PubMed ID: 31969666
[TBL] [Abstract][Full Text] [Related]
4. Sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial adenocarcinomas in vitro and in vivo.
Perrone E; Manara P; Lopez S; Bellone S; Bonazzoli E; Manzano A; Zammataro L; Bianchi A; Zeybek B; Buza N; Tymon-Rosario J; Altwerger G; Han C; Menderes G; Huang GS; Ratner E; Silasi DA; Azodi M; Hui P; Schwartz PE; Scambia G; Santin AD
Mol Oncol; 2020 Mar; 14(3):645-656. PubMed ID: 31891442
[TBL] [Abstract][Full Text] [Related]
5. Mucin immunohistochemistry in the diagnosis and mapping of extramammary Paget's disease.
Smith RF; Stern BH; Smith AA
J Cell Mol Med; 2008; 12(5A):1605-10. PubMed ID: 18081697
[TBL] [Abstract][Full Text] [Related]
6. Targeting Trop2 in solid tumors: a look into structures and novel epitopes.
Liu X; Li J; Deng J; Zhao J; Zhao G; Zhang T; Jiang H; Liang B; Xing D; Wang J
Front Immunol; 2023; 14():1332489. PubMed ID: 38179054
[TBL] [Abstract][Full Text] [Related]
7. A Case Report of Familial Extramammary Paget's Disease in Female Siblings.
Rutnumnoi T; Leeyaphan C
Case Rep Dermatol; 2021; 13(1):176-183. PubMed ID: 34703424
[TBL] [Abstract][Full Text] [Related]
8. CDK4: A Novel Therapeutic Target for Extramammary Paget's Disease.
Hashimoto H; Kaku-Ito Y; Oda Y; Ito T
Front Oncol; 2021; 11():710378. PubMed ID: 34395284
[TBL] [Abstract][Full Text] [Related]
9. Eribulin for patients with metastatic extramammary Paget disease: Study protocol for a single-arm phase II trial.
Maeda T; Yanagi T; Tokuchi K; Funakoshi T; Horie N; Isoe T; Ito YM; Sato N; Ujiie H
Exp Dermatol; 2024 Jan; 33(1):e14993. PubMed ID: 38284191
[TBL] [Abstract][Full Text] [Related]
10. Upregulated expression of glucose transporter isoform 1 in invasive and metastatic extramammary Paget's disease.
Matsumoto M; Rokunohe D; Sasaki T; Matsuzaki Y; Nakano H; Mizukami H; Akasaka E; Sawamura D
Exp Ther Med; 2024 May; 27(5):228. PubMed ID: 38596658
[TBL] [Abstract][Full Text] [Related]
11. Trop2: Jack of All Trades, Master of None.
Lenárt S; Lenárt P; Šmarda J; Remšík J; Souček K; Beneš P
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33187148
[TBL] [Abstract][Full Text] [Related]
12. Loss of TROP2 and epithelial cell adhesion molecule expression is linked to grade progression in pTa but unrelated to disease outcome in pT2-4 urothelial bladder carcinomas.
Müller JH; Plage H; Elezkurtaj S; Mandelkow T; Huang Z; Lurati MCJ; Raedler JB; Debatin NF; Vettorazzi E; Samtleben H; Hofbauer S; Furlano K; Neymeyer J; Goranova I; Ralla B; Weinberger S; Horst D; Roßner F; Schallenberg S; Marx AH; Fisch M; Rink M; Slojewski M; Kaczmarek K; Ecke T; Hallmann S; Koch S; Adamini N; Lennartz M; Minner S; Simon R; Sauter G; Zecha H; Schlomm T; Bady E
Front Oncol; 2023; 13():1342367. PubMed ID: 38282671
[TBL] [Abstract][Full Text] [Related]
13. Extramammary Paget Disease. Part I. Epidemiology, Pathogenesis, Clinical Features, and Diagnosis.
Shah RR; Shah K; Wilson BN; Tchack M; Busam KJ; Moy A; Leitao MM; Cordova M; Neumann NM; Hosein S; Dafinone M; Schwartz RA; Rossi A
J Am Acad Dermatol; 2024 May; ():. PubMed ID: 38704032
[TBL] [Abstract][Full Text] [Related]
14. ImmunoPET imaging of Trop2 in patients with solid tumours.
Huang W; Zhang Y; Cao M; Wu Y; Jiao F; Chu Z; Zhou X; Li L; Xu D; Pan X; Guan Y; Huang G; Liu J; Xie F; Wei W
EMBO Mol Med; 2024 May; 16(5):1143-1161. PubMed ID: 38565806
[TBL] [Abstract][Full Text] [Related]
15. A new TROP2-targeting antibody-drug conjugate shows potent antitumor efficacy in breast and lung cancers.
Zhou DD; Zhai XT; Zhang LW; Xie ZH; Wang Y; Zhen YS; Gao RJ; Miao QF
NPJ Precis Oncol; 2024 Apr; 8(1):94. PubMed ID: 38654141
[TBL] [Abstract][Full Text] [Related]
16. Expression of Potential Antibody-Drug Conjugate Targets in Cervical Cancer.
Mallmann MR; Tamir S; Alfter K; Ratiu D; Quaas A; Domroese CM
Cancers (Basel); 2024 May; 16(9):. PubMed ID: 38730739
[TBL] [Abstract][Full Text] [Related]
17. Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer.
Coates JT; Sun S; Leshchiner I; Thimmiah N; Martin EE; McLoughlin D; Danysh BP; Slowik K; Jacobs RA; Rhrissorrakrai K; Utro F; Levovitz C; Denault E; Walmsley CS; Kambadakone A; Stone JR; Isakoff SJ; Parida L; Juric D; Getz G; Bardia A; Ellisen LW
Cancer Discov; 2021 Oct; 11(10):2436-2445. PubMed ID: 34404686
[TBL] [Abstract][Full Text] [Related]
18. Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer.
Liu X; Deng J; Yuan Y; Chen W; Sun W; Wang Y; Huang H; Liang B; Ming T; Wen J; Huang B; Xing D
Pharmacol Ther; 2022 Nov; 239():108296. PubMed ID: 36208791
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.
Shi D; Li Y; Liang X; Chen L
Front Oncol; 2023; 13():1162360. PubMed ID: 37251935
[TBL] [Abstract][Full Text] [Related]
20. A literature review of the promising future of
Wen Y; Ouyang D; Zou Q; Chen Q; Luo N; He H; Anwar M; Yi W
Ann Transl Med; 2022 Dec; 10(24):1403. PubMed ID: 36660684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
